cvs caremark cigna - Search News

Hosted on MSN · 3h

FTC Slams UnitedHealth (NYSE:UNH), CVS and Cigna PBMs for Inflating Prices by $7.3B

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna

FTC releases new findings in drug price inflation investigation

A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of prescription drugs.

CNN on MSN · 20h

FTC finds middlemen inflate specialty generic drug prices by billions of dollars

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,

Hosted on MSN · 1d

CVS, Cigna, and UnitedHealth inflated cancer and HIV drug prices, FTC says

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion in revenue, The Federal Trade Commission (FTC) said in a report released today.

Bloomberg L.P. · 1d

FTC says CVS, Cigna and UnitedHealth abuse middleman role

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more than $7.

1hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

The report is the latest indictment of America’s broken healthcare system.

2h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

20hon MSN

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

22hon MSN

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Modern Healthcare1d

Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Healthcare Dive1d

FTC releases second report slamming pharmacy benefit managers

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

Pharmalittle: We’re reading about FTC criticizing PBMs, a NIH policy on access to medicines, and more

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results